Polycyclic Cage Structures as Lipophilic Scaffolds for Neuroactive Drugs
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polycyclic Cage Structures as Lipophilic Scaffolds for Neuroactive Drugs
Authors
Keywords
-
Journal
ChemMedChem
Volume 7, Issue 3, Pages 375-384
Publisher
Wiley
Online
2012-02-04
DOI
10.1002/cmdc.201100559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and evaluation of fluorescent heterocyclic aminoadamantanes as multifunctional neuroprotective agents
- (2011) Jacques Joubert et al. BIOORGANIC & MEDICINAL CHEMISTRY
- N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (σ) receptor ligands
- (2011) Samuel D. Banister et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular hybridization of 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity
- (2011) Samuel D. Banister et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, evaluation and application of polycyclic fluorescent analogues as N-methyl-d-aspartate receptor and voltage gated calcium channel ligands
- (2011) Jacques Joubert et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands
- (2010) Samuel D. Banister et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Efficacy and tolerability of rasagiline in daily clinical use - a post-marketing observational study in patients with Parkinson’s disease
- (2010) H. Reichmann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Rasagiline in Parkinson's Disease
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Sigma receptors: Potential targets for a new class of antidepressant drug
- (2010) James A. Fishback et al. PHARMACOLOGY & THERAPEUTICS
- Complement in neuroprotection and neurodegeneration
- (2010) Vijay Yanamadala et al. TRENDS IN MOLECULAR MEDICINE
- Nitric Oxide Synthase Inhibition by Pentacycloundecane Conjugates of Aminoguanidine and Tryptamine
- (2009) Dennis K. Wilkes et al. ARCHIV DER PHARMAZIE
- Oxo-bridged isomers of aza-trishomocubane sigma (σ) receptor ligands: Synthesis, in vitro binding, and molecular modeling
- (2009) Samuel D. Banister et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept
- (2009) Andreas Reichel CHEMISTRY & BIODIVERSITY
- Developments in fluorescent probes for receptor research
- (2009) Marcello Leopoldo et al. DRUG DISCOVERY TODAY
- Polycyclic cage structures as carrier molecules for neuroprotective non-steroidal anti-inflammatory drugs
- (2009) Louis H.A. Prins et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue
- (2009) Werner J. Geldenhuys et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease
- (2009) Tuan Hoang et al. FREE RADICAL BIOLOGY AND MEDICINE
- The neuroprotective mechanism of 1-(R)-aminoindan, the major metabolite of the anti-parkinsonian drug rasagiline
- (2009) Orit Bar-Am et al. JOURNAL OF NEUROCHEMISTRY
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Comparative Neuroprotective Effects of Rasagiline and Aminoindan with Selegiline on Dexamethasone-Induced Brain Cell Apoptosis
- (2009) Shawna Tazik et al. NEUROTOXICITY RESEARCH
- Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesions
- (2008) Addy van Dijk et al. BEHAVIOURAL BRAIN RESEARCH
- Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibition
- (2008) Jacques Joubert et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones
- (2008) Jan Balzarini et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rasagiline in neurodegeneration
- (2008) Anthony H.V. Schapira EXPERIMENTAL NEUROLOGY
- Parkinson's disease: emerging pharmacotherapy
- (2008) Karl Strecker et al. EXPERT OPINION ON EMERGING DRUGS
- Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2
- (2008) D. M. Wilcock et al. JOURNAL OF NEUROSCIENCE
- A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
- (2008) C. Warren Olanow et al. MOVEMENT DISORDERS
- Polycyclic compounds: Ideal drug scaffolds for the design of multiple mechanism drugs?
- (2008) Cornells J. Schyf et al. Neurotherapeutics
- Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs
- (2008) Orly Weinreb et al. Neurotherapeutics
- Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease
- (2008) Jacobus P. Petzer et al. Neurotherapeutics
- Neuroprotection in mice by NGP1-01 after transient focal brain ischemia
- (2007) Jiukuan Hao et al. BRAIN RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now